Experimental evidence shows that CD44 is the most effective membrane protein to bind hyaluronic acid, thus HA has been extensively used in developing nanocarriers that demonstrate preferential tumor accumulation and increased cell uptake in cancer cells [44]. The gene discussed is CD44; the disease is cancer.